Success Metrics

Active Trials

2(50%)

Phase Distribution

Ph phase_2

75%

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

3(75.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Detailed Status

Not yet recruiting2

Recruiting2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 2

Trials by Phase

Phase 23 (75.0%)

N/A1 (25.0%)

Trials by Status

not_yet_recruiting250%

recruiting250%

Recent Activity

2 active trials

Showing 4 of 4

recruitingphase_2

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

NCT07170800

recruitingphase_2

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

NCT06114628

not_yet_recruitingphase_2

Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

NCT07129629

not_yet_recruitingnot_applicable

A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis

NCT07126639

Clinical Trials (4)

Showing 4 of 4 trials

NCT07170800Phase 2

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

Recruiting

NCT06114628Phase 2

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Recruiting

NCT07129629Phase 2

Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

Not Yet Recruiting

NCT07126639Not Applicable

A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis

Not Yet Recruiting

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4